{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-childhood/management/additional-immunizations/","result":{"pageContext":{"chapter":{"id":"df573b46-28ae-516a-adde-90b8bc742b29","slug":"additional-immunizations","fullItemName":"Scenario: Additional immunizations","depth":2,"htmlHeader":"<!-- begin field e3ba1f20-9a70-4133-b3e0-025f315b496a --><h2>Scenario: Additional childhood immunizations</h2><!-- end field e3ba1f20-9a70-4133-b3e0-025f315b496a -->","summary":"Covers the management of children who are at increased risk of particular diseases (tuberculosis, pneumococcal disease, hepatitis B, and influenza).","htmlStringContent":"<!-- begin item 749ed120-564d-467d-b68c-a6e518a7e8ae --><!-- begin field 5b235b15-ccfb-4e33-ab41-acbd008874d8 --><p>From age 2 months to 25 years.</p><!-- end field 5b235b15-ccfb-4e33-ab41-acbd008874d8 --><!-- end item 749ed120-564d-467d-b68c-a6e518a7e8ae -->","topic":{"id":"141a79f8-bf34-5bd6-9d3e-4e2d2e1c98f3","topicId":"884b0998-c242-4b76-869c-7e1d7203ac34","topicName":"Immunizations - childhood","slug":"immunizations-childhood","lastRevised":"Last revised in November 2020","chapters":[{"id":"6ba54a01-de23-5846-8b4d-e24477c75832","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ca5ebce-3bb6-51f5-897f-9f02d913dd37","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"49b0da44-2af1-559a-aa3d-b7492cc9ee0d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"69eb6e91-b113-53eb-bd4e-6a2f49ca6593","slug":"changes","fullItemName":"Changes"},{"id":"0b393c87-257a-567c-b12f-c3d1f55b13aa","slug":"update","fullItemName":"Update"}]},{"id":"ea1bc6cb-f5cf-5581-8659-301af7d9fb67","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f586895e-7f2d-51ef-baa8-6a9a1e98695f","slug":"goals","fullItemName":"Goals"},{"id":"1420f7f8-09c4-58fa-8d52-9b4a3d2a8ddf","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"16ddc68d-be0a-56cd-b38a-9acdf13a0bfe","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"713a5cac-cd5d-58d0-8793-b453d244027d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a6ab4abc-1ddb-5864-9f72-3eb58c16089a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b3ef6d84-ce51-57df-ba8a-40fbd3b7ceee","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e9c4eca9-e338-5ae7-9ad6-cffd74ef6c52","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9a89a8f0-b573-5292-93a2-1ee7ba24d67e","slug":"the-routine-childhood-immunization-schedule","fullItemName":"The routine childhood immunization schedule"},{"id":"fffdcf61-8f20-593c-9fbc-a4de125dab35","slug":"childhood-immunization-programme-coverage","fullItemName":"Childhood immunization programme coverage"}]},{"id":"e9b881e0-0306-56fc-975a-71fc5731b73a","fullItemName":"Management","slug":"management","subChapters":[{"id":"75d2baa6-d689-537b-985d-3b2b1c30e8b3","slug":"children-up-to-1-year-of-age","fullItemName":"Scenario: Children up to 1 year of age"},{"id":"cb326e70-51cb-5b55-86a4-5d1f28fbcf08","slug":"children-1-2-years-of-age","fullItemName":"Scenario: Children 1-2 years of age"},{"id":"6b4cbafe-fdfb-583a-a3fe-7a96b10253c4","slug":"children-2-10-years-of-age","fullItemName":"Scenario: Children 2-10 years of age"},{"id":"88a19f4f-827e-5331-836f-99c46181a1f9","slug":"children-over-10-years-of-age","fullItemName":"Scenario: Children over 10 years of age"},{"id":"df573b46-28ae-516a-adde-90b8bc742b29","slug":"additional-immunizations","fullItemName":"Scenario: Additional immunizations"}]},{"id":"3a2ea091-53a4-51b4-8c1b-16bbc187300b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"39c5bd91-68df-5d37-bdf6-a3fbf4194d8b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e5eea053-f5bc-5745-955b-0200236a454a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"8546e676-a44d-5c1d-a1b9-5d571b466524","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6b8c8a42-fd07-546b-8ec8-59db2829b422","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"913a73f4-d332-5491-a242-fb9e5fed1e37","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8e7e3dc1-7bda-57e5-ba9b-f03e0049b730","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d5fbf31a-ca3a-5b16-86c7-90949cade220","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e9b881e0-0306-56fc-975a-71fc5731b73a","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"bb55800b-5774-5fe7-bcc4-f5fb08e3aa10","slug":"children-requiring-additional-immunization","fullItemName":"Children requiring additional immunization","depth":3,"htmlHeader":"<!-- begin field 02653ed5-2a72-488c-9b72-d76dca2ac5f9 --><h3>Which children require additional immunizations?</h3><!-- end field 02653ed5-2a72-488c-9b72-d76dca2ac5f9 -->","summary":null,"htmlStringContent":"<!-- begin item 1053422f-b0b8-4005-a76b-5ba4e27f366a --><!-- begin field d4e25d29-599f-4264-8cc6-180ab86131a7 --><ul><li><strong>Healthy children will not usually require additional vaccinations other than those provided by the childhood immunization programme.</strong> This is a summary and is not comprehensive. For more information, consult <a href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book\" data-hyperlink-id=\"90f891ea-384e-4581-8066-a8f7014b9f9e\">Immunisation against infectious disease</a> (the 'Green Book') at www.gov.uk.<ul><li>Give additional vaccinations if the child: <ul><li>Has comorbidities which make them susceptible to certain preventable diseases (for example pneumococcal disease, influenza). See Table 2 for information on the additional vaccines required for people with underlying medical conditions.  </li><li>Is, or has been, exposed to an environment where infection with a preventable disease is more likely (for example tuberculosis, hepatitis B).</li><li>Is going to travel to an area outside the UK which is endemic with a preventable disease (for example hepatitis A, typhoid, and yellow fever). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-travel/\">Immunizations - travel</a>.</li></ul></li></ul></li><li><strong>Tuberculosis (TB) </strong><ul><li>Vaccination with Bacillus Calmette–Guérin (BCG) is now targeted at children most at risk, including:<ul><li>Infants younger than 1 year of age who live in areas of the UK with an annual incidence of TB of 40 per 100,000 or greater. For country-specific data, see the World Health Organization's <a href=\"http://www.who.int/tb/country/data/profiles/en/\" data-hyperlink-id=\"6e662759-c20a-47b6-8e92-a8f7014b9fa8\">Tuberculosis country profiles</a>, available at www.who.int.</li><li>Infants younger than 1 year of age who have a parent or grandparent born in a country with an annual incidence of TB of 40 per 100,000 or greater.</li><li>Children 1–5 years of age who are previously unvaccinated and have a parent or grandparent born in a country with an annual incidence of TB of 40 per 100,000 or greater.</li><li>Children 6–16 years of age who are tuberculin-negative, previously unvaccinated, and have a parent or grandparent born in a country with an annual incidence of TB of 40 per 100,000 or greater.</li><li>Children under 16 years of age who are tuberculin-negative, previously unvaccinated, and are contacts of a case of respiratory TB.</li><li>Children under 16 years of age who are tuberculin-negative, previously unvaccinated, and were born, or have lived for at least 3 months, in a country with an annual incidence of TB of 40 per 100,000 or greater.</li></ul></li><li>If a child requires vaccination against tuberculosis, refer according to local policy and service provision.</li></ul></li><li><strong>Hepatitis B</strong> — children considered to be at high risk of exposure to hepatitis B include those:<ul><li>Born to a mother or living with parents or close household contacts known to have hepatitis B.</li><li>Whose parents are people who inject drugs.</li><li>Who receive regular blood transfusions (for example for haemophilia).</li><li>In residential or day care for people with severe learning disability (decisions on immunization should be made on the basis of a local risk assessment).</li><li>Who are at high risk of requiring medical or dental procedures when travelling to visit relatives in countries where there is a moderate or high prevalence of hepatitis B.</li></ul></li><li><strong>Chickenpox </strong>— vaccination is recommended for susceptible children who are close contacts of people who are immunocompromised (for example they have a sibling or parent with leukaemia or undergoing chemotherapy).<ul><li>For children aged one year or older, give two doses of varicella vaccine (Varivax® or Varilrix®) spaced 4–8 weeks apart. </li><li>Varivax® is licensed for vaccination against varicella in children aged 12 months or over. </li><li>Varilrix® is not licensed for routine use in children, but the manufacturer states that it may be given to healthy, seronegative children aged 1–12 years who are close contacts of people considered to be at high risk of severe varicella infection.</li><li>The varicella vaccine and the measles, mumps, and rubella (MMR) vaccine should be spaced four weeks apart if they are not administered on the same day.</li></ul></li><li>For information on vaccination of people with underlying medical conditions at risk of pneumococcal disease, hepatitis B or influenza, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-pneumococcal/\">Immunizations - pneumococcal</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-seasonal-influenza/\">Immunizations - seasonal influenza</a>.</li></ul><p><strong>Table 2. </strong>Additional vaccines required for people with underlying medical conditions.</p><table style=\"border-collapse: collapse; width: 100%;\" border=\"1\"><tbody><tr><td style=\"width: 50%;\"><strong>Medical condition</strong></td><td style=\"width: 50%;\"><strong>Vaccines required*</strong></td></tr><tr><td style=\"width: 50%;\">Asplenia or splenic dysfunction (including due to sickle cell and coeliac disease)</td><td style=\"width: 50%;\"><p>MenACWY, MenB, PCV13 or PPV23, annual flu vaccine</p></td></tr><tr><td style=\"width: 50%;\">Cochlear implants</td><td style=\"width: 50%;\">PCV13 or PPV23 </td></tr><tr><td style=\"width: 50%;\">Chronic respiratory and heart conditions (such as severe asthma, chronic pulmonary disease, or heart failure)</td><td style=\"width: 50%;\">PCV13 or PPV23, annual flu vaccine</td></tr><tr><td style=\"width: 50%;\">Chronic neurological conditions (such as Parkinson's or motor neurone disease, or learning disability)</td><td style=\"width: 50%;\">PCV13 or PPV23, annual flu vaccine</td></tr><tr><td style=\"width: 50%;\">Diabetes</td><td style=\"width: 50%;\">PCV13 or PPV23, annual flu vaccine</td></tr><tr><td style=\"width: 50%;\">Chronic kidney disease (including haemodialysis)</td><td style=\"width: 50%;\">PCV13 or PPV23, annual flu vaccine, hepatitis B</td></tr><tr><td style=\"width: 50%;\">Chronic liver conditions</td><td style=\"width: 50%;\">PCV13 or PPV23, annual flu vaccine, hepatitis A, hepatitis B</td></tr><tr><td style=\"width: 50%;\">Haemophilia</td><td style=\"width: 50%;\">Hepatitis A, hepatitis B</td></tr><tr><td style=\"width: 50%;\">Immunosuppression due to disease or treatment</td><td style=\"width: 50%;\">PCV13 or PPV23, annual flu vaccine</td></tr><tr><td style=\"width: 50%;\">Complement disorders (including those receiving complement inhibitor therapy)</td><td style=\"width: 50%;\">MenACWY, MenB, PCV13 or PPV23, annual flu vaccine</td></tr><tr><td style=\"width: 50%;\" colspan=\"2\"><p>*Pneumococcal conjugate vaccine (PCV13) can be administered to children aged up to 10 years. Pneumococcal polysaccharide vaccine (PPV23) can be administered to children aged 2 years and over.<strong><br></strong></p></td></tr><tr><td colspan=\"2\"><p><strong>Source:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2020</a>]</p></td></tr></tbody></table><!-- end field d4e25d29-599f-4264-8cc6-180ab86131a7 --><!-- end item 1053422f-b0b8-4005-a76b-5ba4e27f366a -->","subChapters":[{"id":"de4f701a-ca81-51cb-a6fc-b6a0b13a6a8b","slug":"basis-for-recommendation-0dc","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 6128810d-8dc2-45ce-a13d-1dec241dae89 --><h4>Basis for recommendation</h4><!-- end field 6128810d-8dc2-45ce-a13d-1dec241dae89 -->","summary":null,"htmlStringContent":"<!-- begin item 0dcbe7c5-ee51-4e2f-855d-37dd55c5312a --><!-- begin field 6f71d01f-4d7a-4ef6-b721-2475a184c6a2 --><p>These recommendations are based on the <em>Immunisation against infectious disease</em> ('Green Book') chapters on Pneumococcal disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013g</a>], Tuberculosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013p</a>], Influenza [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015m</a>], Varicella [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015n</a>], and Hepatitis B [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016j</a>], the Public Health England (PHE) documents <em>Routine childhood immunisations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016e</a>] and <em>Complete routine immunisation schedule</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2020</a>], and the manufacturers' Summaries of Product Characteristics for Varivax® [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">ABPI Medicines Compendium, 2013</a>] and Varilrix® [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">ABPI Medicines Compendium, 2015b</a>].</p><h5>Timing of the varicella vaccine and the measles, mumps and rubella (MMR) vaccine</h5><ul><li>This recommendation is based on expert opinion from the document <em>Revised recommendations for the administration of more than one live vaccine</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015o</a>] and <em>Immunisation against infectious disease</em> (the 'Green book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013c</a>], published by PHE. These sources state that live vaccines should ideally be given together in order for each vaccine to trigger an appropriate immune response. If another live vaccine is given during the time of the immune response to the first vaccine, the response to the second vaccine may be attenuated. This is thought to be the case for MMR and varicella vaccines, therefore a 4-week interval is suggested if they cannot be given at the same time.</li></ul><!-- end field 6f71d01f-4d7a-4ef6-b721-2475a184c6a2 --><!-- end item 0dcbe7c5-ee51-4e2f-855d-37dd55c5312a -->","subChapters":[]}]},{"id":"da7bbce2-bb29-55f3-82bc-65bb237514f0","slug":"administering-additional-immunizations","fullItemName":"Administering additional immunizations","depth":3,"htmlHeader":"<!-- begin field 47b3bc06-aea0-463f-a5c2-e3ffe94de979 --><h3>How should I administer vaccines in children requiring additional immunization?</h3><!-- end field 47b3bc06-aea0-463f-a5c2-e3ffe94de979 -->","summary":null,"htmlStringContent":"<!-- begin item 3ecfd360-1d7c-4dcb-99f1-47d27a7e984e --><!-- begin field 8fb0359d-bf9a-47e9-ab03-ec2f20bcef67 --><ul><li><strong>Obtain written or verbal consent from a person with parental responsibility,</strong> at the time of vaccination.<ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, they believe it, and they can consider the facts and make an informed decision.</li><li>Young people 16 and 17 years of age are also presumed to be competent using the same criteria as older adults.</li><li>Younger people can also give consent if they fully understand what is involved, but ideally someone with parental responsibility should also be involved.</li></ul></li><li><strong>Ensure that: </strong><ul><li>There are no contraindications to the vaccine (for example, the presence of significant immunosuppression before administering live attenuated vaccines).</li><li>The person, parent, or carer has been fully informed about the vaccine and the vaccination procedure.</li><li>Possible adverse reactions have been discussed and the person, parent or carer is aware of how to manage them. </li></ul></li><li><strong>Check that the vaccine is correct, has been stored appropriately, and has not expired. </strong></li><li><strong>When administering the vaccine:</strong><ul><li>Wash the site with soap and water only if it is visibly dirty.</li><li>The varicella vaccine is given by deep subcutaneous injection (Varivax<sup>®</sup> can also be given intramuscularly).</li><li>BCG is usually given by intradermal injection at designated centres.</li><li>For more information on the administration of the hepatitis B, influenza, and pneumococcal vaccinations, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-seasonal-influenza/\">Immunizations - seasonal influenza</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-pneumococcal/\">Immunizations - pneumococcal</a>.</li><li>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.  </li></ul></li><li><strong>Observe the person after vaccination</strong> to detect immediate adverse reactions. Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare, and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field 8fb0359d-bf9a-47e9-ab03-ec2f20bcef67 --><!-- end item 3ecfd360-1d7c-4dcb-99f1-47d27a7e984e -->","subChapters":[{"id":"7a59a06e-9eff-5628-bb43-11803e28053f","slug":"basis-for-recommendation-7d2","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 73ce3a39-5b84-4963-9150-dbc26c394322 --><h4>Basis for recommendation</h4><!-- end field 73ce3a39-5b84-4963-9150-dbc26c394322 -->","summary":null,"htmlStringContent":"<!-- begin item 7d2ba2d9-e2ad-417e-ac97-d20fe68d3f34 --><!-- begin field 9f47814e-38bc-4f90-9456-99e608a2754b --><p>These recommendations are based on chapters in <em>Immunisation against infectious disease</em> (the 'Green Book'), published by Public Health England [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013m</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013n</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013l</a>], and what CKS considers to be good clinical practice.</p><h5>Consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013m</a>]. </li><li>The information regarding consent in young people aged 16–17 years of age and children younger than 16 years of age is based on the <em>Reference guide to consent for examination or treatment</em> from the Department of Health [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">DH, 2009</a>].</li></ul><h5>Site of administration</h5><ul><li>The information on administration of the varicella vaccine is based on the manufacturer's Summaries of Product Characteristics for Varilrix<sup>®</sup> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">ABPI Medicines Compendium, 2015b</a>] and Varivax<sup>®</sup> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">ABPI Medicines Compendium, 2013</a>].</li><li>The information on the administration of the Bacillus Calmette-Guérin (BCG) vaccine is based on the chapter on Tuberculosis in <em>Immunisation against infectious disease</em> (the 'Green book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013p</a>].</li></ul><!-- end field 9f47814e-38bc-4f90-9456-99e608a2754b --><!-- end item 7d2ba2d9-e2ad-417e-ac97-d20fe68d3f34 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}